Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?
Multisystem inflammatory syndrome (MIS) is a new systemic inflammatory acute onset disease that mainly affects children (MIS-C) and, at a lesser frequency, adults (MIS-A); it typically occurs 3–6 weeks after acute SARS-CoV infection. It has been postulated and shown in adults that MIS may occur afte...
Guardado en:
Autores principales: | Reiner Buchhorn, Carlotta Meyer, Kai Schulze-Forster, Juliane Junker, Harald Heidecke |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2bd91cc185834d0abdb615b809d7ce73 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later
por: Megan Striha, et al.
Publicado: (2021) -
Paediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Infection: A Case Series
por: Aneesha Mathew, et al.
Publicado: (2021) -
A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children – literature review based on two case reports
por: Agnieszka Poniecka, et al.
Publicado: (2021) -
Hashimoto's Thyroiditis: Lingual and Labial Capillary Microcirculation in Patients Affected by Macroglossia
por: Scardina,G. A., et al.
Publicado: (2007) -
Distinguishing Between Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children and the Kawasaki Disease: Development of Preliminary Criteria Based on the Data of the Retrospective Multicenter Cohort Study
por: Mikhail M. Kostik, et al.
Publicado: (2021)